Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)

Clinical trial NCT03886038 · COMPLETED

Trial details

NCT number: NCT03886038
Sponsor: Region Skane
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Healthy Controls

Start date: 2019-03-15
Primary completion: 2022-02-15
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.